. Schematic representation of patient and sample selection. Of the 61 patients, 6 patients had high quality formalin fixed paraffin embedded (FFPE) paired tumor biopsies sufficient for WES analyses. The remainder of the patients were not eligible due to a lack of sufficient tumor tissue or to low coverage. 
. Schematic representation of patient and sample selection. Of the 61 patients, 6 patients had high quality formalin fixed paraffin embedded (FFPE) paired tumor biopsies sufficient for WES analyses. The remainder of the patients were not eligible due to a lack of sufficient tumor tissue or to low coverage. Figure S4 . Schematic representation of location and type of mutations in SOCS1, PIM1, and MYC. In line with the literature, there are no specific hotspots. Symbols represent whether a mutation was found in the primary sample, relapse sample, or both. Mutations with black symbols are possibly related to therapy resistance (mutant alle frequency ≥20% and at least two times higher in the relapse sample compared to the primary tumor). Table S4 . List of kinases (n = 18), JAK-STAT signaling (n = 7), and glycoprotein (n = 73) genes with mutations possibly related to therapy resistance. 
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